ATE52141T1 - Immuntest, mittel und verfahren zur bestimmung von natuerlichem und ungewoehnlichem humanprothrombin. - Google Patents

Immuntest, mittel und verfahren zur bestimmung von natuerlichem und ungewoehnlichem humanprothrombin.

Info

Publication number
ATE52141T1
ATE52141T1 AT85307407T AT85307407T ATE52141T1 AT E52141 T1 ATE52141 T1 AT E52141T1 AT 85307407 T AT85307407 T AT 85307407T AT 85307407 T AT85307407 T AT 85307407T AT E52141 T1 ATE52141 T1 AT E52141T1
Authority
AT
Austria
Prior art keywords
immunotest
methods
human prothrombin
determining natural
unusual human
Prior art date
Application number
AT85307407T
Other languages
English (en)
Inventor
Bruce E Furie
Barbara C Furie
Rita A Blanchard
Original Assignee
New England Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Medical Center Inc filed Critical New England Medical Center Inc
Application granted granted Critical
Publication of ATE52141T1 publication Critical patent/ATE52141T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3038—Kidney, bladder
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
AT85307407T 1984-10-15 1985-10-15 Immuntest, mittel und verfahren zur bestimmung von natuerlichem und ungewoehnlichem humanprothrombin. ATE52141T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/661,187 US4769320A (en) 1982-07-27 1984-10-15 Immunoassay means and methods useful in human native prothrombin and human abnormal prothorombin determinations
EP85307407A EP0182495B1 (de) 1984-10-15 1985-10-15 Immuntest, Mittel und Verfahren zur Bestimmung von natürlichem und ungewöhnlichem Human-Prothrombin

Publications (1)

Publication Number Publication Date
ATE52141T1 true ATE52141T1 (de) 1990-05-15

Family

ID=24652562

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85307407T ATE52141T1 (de) 1984-10-15 1985-10-15 Immuntest, mittel und verfahren zur bestimmung von natuerlichem und ungewoehnlichem humanprothrombin.

Country Status (5)

Country Link
US (1) US4769320A (de)
EP (1) EP0182495B1 (de)
JP (1) JPS61117457A (de)
AT (1) ATE52141T1 (de)
DE (1) DE3577233D1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258938B1 (en) * 1983-10-28 2001-07-10 Ne Medical Center Hospital, Inc. Method for the purification and isolation of blood clotting proteins using conformation specific antibodies
DE3727610A1 (de) * 1987-08-19 1989-03-02 Behringwerke Ag Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung
US5147779A (en) * 1988-06-01 1992-09-15 Miles Inc. Method for evaluating immunogenicity
US5272263A (en) * 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US5217870A (en) * 1989-04-28 1993-06-08 Biogen, Inc. Monoclonal antibodies against CDX
US5532136A (en) * 1993-06-22 1996-07-02 Bionebraska, Inc. Monoclonal antibody assay and kit for detecting metal cations in body fluids
US20020040008A1 (en) * 1995-01-24 2002-04-04 Wagner Denisa D. Method for treating and preventing atherosclerosis
CA2230887A1 (en) * 1996-07-27 1998-02-05 Hiroyoshi Nishihara Light emitting device, socket device and lighting device
US5935802A (en) * 1998-08-10 1999-08-10 Evanston Northwestern Healthcare Research Institute Method of assaying a blood sample for prothrombin
CA2378711A1 (en) 1999-08-14 2001-02-22 November Aktiengesellschaft Gesellschaft Fur Molekulare Medizin Method for indirectly determining the blood-clotting status
DE19941447C2 (de) * 1999-08-14 2002-06-27 November Ag Molekulare Medizin Verfahren zur indirekten Bestimmung des Blutgerinnungsstatus
KR100988188B1 (ko) * 2002-12-26 2010-10-18 니토 보세키 가부시기가이샤 면역 측정 방법 및 그것에 이용하는 키트
KR102057826B1 (ko) 2008-04-11 2019-12-20 추가이 세이야쿠 가부시키가이샤 복수 분자의 항원에 반복 결합하는 항원 결합 분자
TWI440469B (zh) 2008-09-26 2014-06-11 Chugai Pharmaceutical Co Ltd Improved antibody molecules
US8283162B2 (en) 2009-03-10 2012-10-09 Abbott Laboratories Antibodies relating to PIVKAII and uses thereof
TWI761912B (zh) * 2010-11-30 2022-04-21 日商中外製藥股份有限公司 具有鈣依存性的抗原結合能力之抗體
SG192945A1 (en) 2011-02-25 2013-09-30 Chugai Pharmaceutical Co Ltd Fcgriib-specific fc antibody
TW201817744A (zh) 2011-09-30 2018-05-16 日商中外製藥股份有限公司 具有促進抗原清除之ＦｃＲｎ結合域的治療性抗原結合分子
JP6322411B2 (ja) 2011-09-30 2018-05-09 中外製薬株式会社 複数の生理活性を有する抗原の消失を促進する抗原結合分子
BR112017011235A2 (pt) 2014-12-19 2018-02-06 Chugai Pharmaceutical Co Ltd anticorpos anti-c5 e métodos de uso
EP4600372A3 (de) 2014-12-19 2025-11-19 Chugai Seiyaku Kabushiki Kaisha Anti-myostatin-antikörper, polypeptide mit abweichenden fc-regionen und verfahren zur verwendung
CN114773469B (zh) 2015-02-05 2025-12-19 中外制药株式会社 包含离子浓度依赖性的抗原结合结构域的抗体，fc区变体，il-8-结合抗体及其应用
TWI805046B (zh) 2015-02-27 2023-06-11 日商中外製藥股份有限公司 Il-6受體抗體用於製備醫藥組成物的用途
WO2017110981A1 (en) 2015-12-25 2017-06-29 Chugai Seiyaku Kabushiki Kaisha Anti-myostatin antibodies and methods of use
CN107727864A (zh) * 2016-07-01 2018-02-23 首都医科大学附属北京佑安医院 一种检测血清中异常脱羧凝血酶原的蛋白芯片、试剂盒及其制备方法
KR102102734B1 (ko) 2016-08-05 2020-04-22 추가이 세이야쿠 가부시키가이샤 Il-8 관련 질환의 치료용 또는 예방용 조성물
EP3574010A4 (de) 2017-01-30 2020-12-16 Chugai Seiyaku Kabushiki Kaisha Anti-sclerostin-antikörper und verfahren zur verwendung
US11851486B2 (en) 2017-05-02 2023-12-26 National Center Of Neurology And Psychiatry Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils
WO2019161491A1 (en) 2018-02-20 2019-08-29 Prominent Medical Inc. Aluminum oxide surfaces and interface molecules

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6060557A (ja) * 1983-09-13 1985-04-08 Eisai Co Ltd Ｐｉｖｋａ−２の測定方法および試薬

Also Published As

Publication number Publication date
US4769320A (en) 1988-09-06
DE3577233D1 (de) 1990-05-23
EP0182495A1 (de) 1986-05-28
JPH0441000B2 (de) 1992-07-06
JPS61117457A (ja) 1986-06-04
EP0182495B1 (de) 1990-04-18

Similar Documents

Publication Publication Date Title
ATE52141T1 (de) Immuntest, mittel und verfahren zur bestimmung von natuerlichem und ungewoehnlichem humanprothrombin.
DE3586159D1 (de) Zusammensetzung und verfahren zur differenzierung von weissen blutzellen.
DE68923981D1 (de) Verfahren zur Bestimmung von Textteilen und Verwendung.
DE68903884D1 (de) Mittel und methode zur bestimmung von spurenmengen an proteinen.
ATA328286A (de) Zell-linien und verfahren zur herstellung von humanen monoklonalen antikörpern sowie kit und verfahren zur bestimmung der anwesenheit von p.aeruginosa
ATE148923T1 (de) Funktioneller test und reagenz zur bestimmung von fibrinogen
AT389590B (de) Verfahren zur kontinuierlichen, quantitativen bestimmung von schwefeldioxid und anordnung zur durchfuehrung des verfahrens
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
AT363617B (de) Verfahren zur direkten bestimmung von eisen im blutserum und reagens zur durchfuehrung des verfahrens
DE3485615D1 (de) Reinigung eines krebsassoziierten proteins und herstellung eines antikoerpers dazu.
DE3668068D1 (de) Mittel und verfahren zur bestimmung von calcium.
DE3889765D1 (de) Reagens und Verfahren zur Bestimmung von Kationen.
DE3777460D1 (de) Verfahren zur bestimmung von leitendem material in glasfasern und geraet dazu.
AT362530B (de) Verfahren und reagens zur bestimmung von glutamat-oxalacetat-transaminase und glutamat- -pyruvat-transaminase
PT85992A (de) Verfahren zur bestimmung von anti-hiv, mittel dazu und ihre verwendung in diesem verfahren
DE3787706D1 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
AT363612B (de) Verfahren und mittel zur bestimmung von alfaamylase
DE3785380D1 (de) Analytische zusammensetzung, element und verfahren zur bestimmung von wasserstoffperoxid.
ATA338987A (de) Verfahren zur bestimmung von anti-p.falciparum- sporozoit-antikörpern im menschlichen blut
FI841145A7 (fi) Menetelmä hemoglobiinipitoisuuden kvantitatiiviseksi määrittämiseksi biologisessa näytteessä.
DE3883808D1 (de) Testsatz, Extraktionsvorrichtung und Verfahren zur Bestimmung von Streptococcus-A-Antigen.
DE59208543D1 (de) Künstliche Standard- und Kontrollseren zur Verwendung in Verfahren zur Bestimmung von Antikörpern
DE68907377D1 (de) Agens und geraet zur bestimmung von antigenen oder antikoerpern.
ATE79475T1 (de) Verfahren zur bestimmung von immunoglobulin-aprotease.
DE3679763D1 (de) Verfahren und zusammensetzungen zur bestimmung von heparin.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee